跳至主要内容
临床试验/NCT03515421
NCT03515421已完成不适用

Project Frazier 3 Regulatory Clinical Evaluation

LifeScan Scotland Ltd8 个研究点 分布在 2 个国家目标入组 379 人开始时间: 2018年4月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
379
试验地点
8
主要终点
User Performance (UP) evaluation measured by blood glucose level (mg/dl) of BGMS vs reference instrument.

研究概览

简要总结

Clinical Evaluation of Blood Glucose Monitoring Systems (BGMSs)

详细描述

User performance, system use, system accuracy, user instruction for use and marketing claims evaluation of Blood Glucose Monitoring Systems.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Summary of Inclusion Criteria
  • Age - Subject is at least 12 years old.
  • Informed Consent - Subject reads the appropriate Participant Information Sheet and signs the Informed Consent Form (section 12.0).
  • Diabetes Diagnosis when applicable - type 1 or type 2 diabetes mellitus.
  • Language - Subject reads and understands local language
  • SMBG status confirmed
  • Subject agrees to complete all aspects of the study

排除标准

  • Conflict of Interest
  • Pregnancy - Subject is pregnant (as confirmed by Subject)
  • User Performance Accuracy Testing - Technical Expertise

结局指标

主要结局

User Performance (UP) evaluation measured by blood glucose level (mg/dl) of BGMS vs reference instrument.

时间窗: Up to 1 hour

UP evaluation of blood glucose monitoring systems compared to a reference instrument. BGMSs samples collected by subject and reference samples collected by HCP ( Health Care Professional)

Instructions for Use Evaluation questionnaire.

时间窗: Up to 10 days.

Questionnaires to assess the effectiveness of the instructions for use.

System Accuracy (SA) evaluation measured by blood glucose level(mg/dl) of BGMSs vs reference instrument.

时间窗: Up to 1 hour

Accuracy verification of blood glucose monitoring systems compared to a reference instrument. Samples collected by HCP only.

System Use Evaluation questionnaire

时间窗: Up to 15 minutes

Assessment of how the patient uses the BGMS.

Marketing Claims Evaluation questionnaire.

时间窗: Up to 10 days

Assess Lay User Acceptance of the Frazier 3 BGMSs in support of marketing claims.

次要结局

未报告次要终点

研究者

发起方
LifeScan Scotland Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验